NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 19.4
(-8.92%)
TWD 19.4
(-8.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 698.45 Million TWD | 0.84% |
| 2022 | 692.6 Million TWD | -1.7% |
| 2021 | 704.57 Million TWD | 7.04% |
| 2020 | 658.23 Million TWD | 8.51% |
| 2019 | 606.64 Million TWD | 98.16% |
| 2018 | 306.13 Million TWD | -0.68% |
| 2017 | 308.22 Million TWD | -12.11% |
| 2016 | 350.68 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 700.91 Million TWD | 0.0% |
| 2024 Q1 | 700.91 Million TWD | 0.35% |
| 2023 FY | 698.45 Million TWD | 0.84% |
| 2023 Q3 | 698.45 Million TWD | 1.87% |
| 2023 Q4 | 698.45 Million TWD | 0.0% |
| 2023 Q2 | 685.61 Million TWD | 0.0% |
| 2023 Q1 | 685.61 Million TWD | -1.01% |
| 2022 FY | 692.6 Million TWD | -1.7% |
| 2022 Q4 | 692.6 Million TWD | 0.0% |
| 2022 Q2 | 719.36 Million TWD | 0.0% |
| 2021 Q2 | 638.9 Million TWD | 0.0% |
| 2021 FY | 704.57 Million TWD | 7.04% |
| 2021 Q4 | 704.57 Million TWD | 0.0% |
| 2020 Q4 | 658.23 Million TWD | 0.0% |
| 2020 FY | 658.23 Million TWD | 8.51% |
| 2020 Q2 | 656.04 Million TWD | 0.0% |
| 2019 Q4 | 606.64 Million TWD | 0.0% |
| 2019 FY | 606.64 Million TWD | 98.16% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -445.465% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 75.923% |
| Level Biotechnology Inc. | 822.67 Million TWD | 15.1% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -5.074% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -27.281% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 82.063% |
| GlycoNex Incorporation | 1.55 Billion TWD | 55.02% |
| VBI | 452.1 Million TWD | -54.49% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 40.615% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 6.695% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -84.599% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 38.4% |
| Visgeneer Inc. | 397.17 Million TWD | -75.854% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 81.475% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 67.65% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 20.909% |
| Neith Corporation | 192.15 Million TWD | -263.487% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 88.536% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -849.524% |
| Enimmune corporation | 604.82 Million TWD | -15.479% |
| TaiRx, Inc. | 833.74 Million TWD | 16.227% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 77.367% |
| EirGenix Inc. | 11.16 Billion TWD | 93.743% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -21.864% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 59.211% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 80.581% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 33.511% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -132.019% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -163.908% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -58.31% |
| RBC Bioscience Corporation | 753.79 Million TWD | 7.341% |
| BiOptic Inc. | 613.77 Million TWD | -13.796% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 60.732% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 39.774% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -8.312% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 77.515% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -372.137% |
| NaviFUS Corp. | 490.53 Million TWD | -42.386% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 43.017% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 48.77% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -31.996% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 39.861% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 57.83% |
| AP Biosciences Inc | 890.75 Million TWD | 21.589% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 91.809% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -115.473% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 47.628% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 74.237% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 95.454% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -70.247% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -75.998% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 66.355% |
| TCI GENE Inc. | 1.16 Billion TWD | 40.095% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -137.1% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 48.769% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 25.836% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 82.335% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 81.729% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 43.208% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 87.536% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 34.233% |
| Acepodia, Inc. | 6.81 Billion TWD | 89.757% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 81.747% |